abstract |
The invention relates to synthetic isohirudins which, owing to exchange in the region of the Asp-Gly motifs, have improved stability. This results, on the one hand, in an increased yield during working up and, on the other hand, in a pharmaceutical formulation as directly injectable solution being possible. <IMAGE> |